Personalized algorithms help improve walking in Parkinson’s
Using mathematical models, researchers at the University of California, San Francisco (UCSF) successfully predicted how to adjust deep brain…
Lila is a Science Writer at BioNews. She completed her PhD in neuroscience at the University of Washington, where she studied how the natural flexibility of the human brain can be used to promote recovery after injury. Previously, she has written about science for The Dallas Morning News and the University of Washington Computational Neuroscience Center. She enjoys exploring the Pacific Northwest and spending time with her cat, Fibonacci.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Using mathematical models, researchers at the University of California, San Francisco (UCSF) successfully predicted how to adjust deep brain…
When combined with deep brain stimulation (DBS), a dynamic, cycling-based exercise program for people with Parkinson’s disease produces…
Infection with a common and otherwise harmless virus called human pegivirus (HPgV) might play a hidden role in Parkinson’s…
Neu Health is launching its smartphone-based system to measure tremors in people with Parkinson’s disease in the U.S.
Neuraxpharm is partnering with Dizlin Pharmaceuticals on Dizlin’s Infudopa SubC drug-device combination therapy, which allows for continuous levodopa-carbidopa…
An experimental theater program improved the emotional well-being of people with Parkinson’s disease, and eased their anxiety and depression, a…
Ambroxol, a common cough medicine, may help stabilize neuropsychiatric symptoms in Parkinson’s disease dementia (PDD) and shows cognitive promise for…
Genetic analysis of saliva may offer a noninvasive way to assess the risk of developing Parkinson’s disease, according to…
Note: This story was updated Oct. 7, 2025, to correct the headline and first paragraph to reflect that while Pharmather…
BioVie’s ongoing SUNRISE-PD clinical trial of bezisterim in early Parkinson’s disease uses a hybrid, decentralized approach to center patient…
Get regular updates to your inbox.